van Dijk Marcus Antonius has filed 5 insider transactions across 1 company since January 2023.
Most recent transaction: a grant/award of 15000 shares of MiNK Therapeutics, Inc. ($INKT) on January 16, 2024.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 16, 2024 | MiNK Therapeutics, Inc. | $INKT | van Dijk Marcus Antonius | Chief Scientific Officer | A | Stock Option | 15000 | $0.00 | 15,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 16, 2024 | MiNK Therapeutics, Inc. | $INKT | van Dijk Marcus Antonius | Chief Scientific Officer | A | Stock Option | 171078 | $0.00 | 171,078.0000 | 0 | 9999.99% | 0.00% |
| Jan. 9, 2023 | MiNK Therapeutics, Inc. | $INKT | van Dijk Marcus Antonius | Chief Scientific Officer | A | Common Stock | 51628 | $2.32 | 51,628.0000 | 0 | 9999.99% | 0.00% |
| Jan. 9, 2023 | MiNK Therapeutics, Inc. | $INKT | van Dijk Marcus Antonius | Chief Scientific Officer | F | Common Stock | 24265 | $2.32 | 27,363.0000 | 0 | 47.00% | 0.00% |
| Jan. 9, 2023 | MiNK Therapeutics, Inc. | $INKT | van Dijk Marcus Antonius | Chief Scientific Officer | A | Stock Option | 15000 | $0.00 | 15,000.0000 | 0 | 9999.99% | 0.00% |